Lapine T-Lymphocyte Immune Globulin ( DrugBank: Lapine T-lymphocyte immune globulin )


4 diseases
IDDisease name (Link within this page)Number of trials
62Paroxysmal nocturnal hemoglobinuria1
65Primary immunodeficiency1
283Acquired pure red cell aplasia1
286Hereditary sideroblastic anemia1

62. Paroxysmal nocturnal hemoglobinuria


Clinical trials : 292Drugs : 151 - (DrugBank : 49) / Drug target genes : 22 - Drug target pathways : 108 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

65. Primary immunodeficiency


Clinical trials : 500Drugs : 614 - (DrugBank : 119) / Drug target genes : 92 - Drug target pathways : 217 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

283. Acquired pure red cell aplasia


Clinical trials : 19Drugs : 36 - (DrugBank : 23) / Drug target genes : 20 - Drug target pathways : 102 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

286. Hereditary sideroblastic anemia


Clinical trials : 7Drugs : 20 - (DrugBank : 10) / Drug target genes : 8 - Drug target pathways : 43 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries